Inebilizumab Monotherapy in Relapsing IgG4-Related Tubulointerstitial Nephritis

By afschroeder • October 7, 2026

Ebrahimi N, Ha V, Glassock RJ, Rastogi A, Norouzi S. Inebilizumab Monotherapy in Relapsing IgG4-Related Tubulointerstitial Nephritis. Kidney Int Rep. 2026 Aug 24;11(11):107055. doi: 10.1016/j.ekir.2026.107055. PMID: 42835082; PMCID: PMC13634876.

Tags: Nephrology, Publications

Comparative Renal Effectiveness of GLP-1RA and SGLT2i in US Veterans with Type 2 Diabetes and CKD

Htoo PT, Patorno E, Ortega-Montiel J, Wexler DJ, Orkaby A, Paik JM. Comparative Renal Effectiveness of GLP-1RA and SGLT2i in US Veterans with Type 2[...]

Suspected Pembrolizumab-Associated Perinuclear Antineutrophil Cytoplasmic Antibody (p-ANCA) Vasculitis With Progressive Kidney Injury in a Patient With Metastatic Renal Cell Carcinoma and Limited Renal Reserve: A Diagnostic Challenge

Goshtaseb R, Luu Y, Sarmosyan K, Lopez L, Drakaki A. Suspected Pembrolizumab-Associated Perinuclear Antineutrophil Cytoplasmic Antibody (p-ANCA) Vasculitis With Progressive Kidney Injury in a Patient[...]

Engineering an Artificial Kidney

Goodrich J, Marçal J, Hestekin C, Hestekin J, Kurtz I. Engineering an Artificial Kidney. Clin J Am Soc Nephrol. 2026 Sep 24. doi: 10.2215/CJN.0000001251. Epub[...]